PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10845669-8	2000	The effect of FK506 treatment on NK1.1+ LAL was tested by cell-sorting and cytotoxicity assay.	Tacrolimus	14-19	killer cell lectin-like receptor subfamily B member 1C	Mus musculus	33-38	
10845669-10	2000	RESULTS: Both FK506 treatment and oral tolerance induced a significant increase in NK1.1+ LAL number and cytotoxicity function.	Tacrolimus	14-19	killer cell lectin-like receptor subfamily B member 1C	Mus musculus	83-88	
10845669-13	2000	CONCLUSIONS: This study shows for the first time that immune tolerance induced by both oral administration of an antigen and by FK506 treatment may be mediated via enhancement of NK1.1+ LAL.	Tacrolimus	128-133	killer cell lectin-like receptor subfamily B member 1C	Mus musculus	179-184